医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
34期
61-62
,共2页
热疗%放疗%化疗%宫颈癌
熱療%放療%化療%宮頸癌
열료%방료%화료%궁경암
Hyperthermia%Radiotherapy%Chemotherapy%Cervical carcinoma
目的：研究热、放、化疗三联合治疗宫颈癌的临床疗效。方法：宫颈癌患者随机分为综合组（热疗结合同步放化疗组）和照组（单纯同步放化疗组），综合组41例均行放疗加化疗、热疗；对照组43例放疗加化疗。结果：综合组和对照组近期疗效（3个月总有效率）、1、3年生存率分别为90.24%、97.56%、78.05%；72.09%、88.37%、55.81%，两组比较近期疗效、3年生存率有差异（p＜0.05），而1年生存率无差异（p＞0.05）。结论：热疗结合同步放化疗是提高宫颈癌近期疗效、3年生存的有效方法。
目的：研究熱、放、化療三聯閤治療宮頸癌的臨床療效。方法：宮頸癌患者隨機分為綜閤組（熱療結閤同步放化療組）和照組（單純同步放化療組），綜閤組41例均行放療加化療、熱療；對照組43例放療加化療。結果：綜閤組和對照組近期療效（3箇月總有效率）、1、3年生存率分彆為90.24%、97.56%、78.05%；72.09%、88.37%、55.81%，兩組比較近期療效、3年生存率有差異（p＜0.05），而1年生存率無差異（p＞0.05）。結論：熱療結閤同步放化療是提高宮頸癌近期療效、3年生存的有效方法。
목적：연구열、방、화료삼연합치료궁경암적림상료효。방법：궁경암환자수궤분위종합조（열료결합동보방화료조）화조조（단순동보방화료조），종합조41례균행방료가화료、열료；대조조43례방료가화료。결과：종합조화대조조근기료효（3개월총유효솔）、1、3년생존솔분별위90.24%、97.56%、78.05%；72.09%、88.37%、55.81%，량조비교근기료효、3년생존솔유차이（p＜0.05），이1년생존솔무차이（p＞0.05）。결론：열료결합동보방화료시제고궁경암근기료효、3년생존적유효방법。
Objective: To investigate clinical effects of hyperthermia combined with radiotherapy concurrently combined with chemotherapy in treatment of cervical carcinoma. Methods: The patients with cervical carcinoma were randomly divided into combined group and control group, combined group were received hyperthermia combined with radiotherapy and chemotherapy concurrently, control group were treated by radiotherapy combined with chemotherapy. Results: combined group VS. control group, recent effects,1、3-year survival rates were respectively 90.24%、97.56%、78.05%; 72.09%、88.37%、55.81%, there were differences in recent effects,3-year survival rates between two groups (p<0.05), while, 1-year survival rates had no differences(p>0.05). Conclusions:Hyperthermia combined with radiotherapy concurrently combined with chemotherapy was a effective method in the pursuit of recent effects、3-year rates benefits for cervical carcinoma.
